CTP Inhibitors
Drug / Medication
A class of drugs designed to raise HDL cholesterol; trials have largely failed to improve outcomes, supporting the idea that HDL manipulation is not causally linked to reduced cardiovascular events.
Mentioned in 2 videos
Save the 2 videos on CTP Inhibitors to your own pod.
Sign up free to keep building your knowledge base on CTP Inhibitors as more episodes are added.
Videos Mentioning CTP Inhibitors
Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast
Peter Attia MD
A class of drugs that proved manipulating HDL cholesterol does not change cardiovascular outcomes, providing evidence that HDL is not causal.
229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
Peter Attia MD
A class of drugs designed to raise HDL cholesterol; trials have largely failed to improve outcomes, supporting the idea that HDL manipulation is not causally linked to reduced cardiovascular events.